|1.||Parrot-Lopez, Hélène: 1 article (01/2013)|
|2.||Zeinyeh, Wael: 1 article (01/2013)|
|3.||Jose, Joachim: 1 article (01/2013)|
|4.||Marminon, Christelle: 1 article (01/2013)|
|5.||Bollacke, Andre: 1 article (01/2013)|
|6.||Perret, Florent: 1 article (01/2013)|
|7.||Le Borgne, Marc: 1 article (01/2013)|
|8.||Nebois, Pascal: 1 article (01/2013)|
|9.||Pierré, Alain: 1 article (11/2004)|
|10.||Boussard, Marie-Françoise: 1 article (11/2004)|
01/01/2001 - "The effects of H290/51, a novel indenoindole derivative inhibitor of lipid peroxidation, on ultrastructural changes during cardiac ischemia-reperfusion injury were investigated. "
03/15/1998 - "The indenoindole H290/51, a lipid peroxidation inhibitor with balanced lipophilicity and a considerably higher antioxidative capacity than that of vitamin E, was tested for its myocardioprotective effect against reperfusion injury. "
01/30/2013 - "Based on these results, encapsulation within fluorinated amphiphilic CD nanoparticles could be considered as a potential drug delivery system for indenoindole-type CK2 inhibitors, allowing better biodisponibility and offering perspectives for tumor targeting development."
11/15/2004 - "We have identified a novel series of indenoindole derivatives endowed with potent cytotoxic activities toward cancer cells. "
|4.||Body Weight (Weight, Body)
|2.||Ornithine Carbamoyltransferase (Ornithine Transcarbamylase)
|6.||Alanine Transaminase (SGPT)
|7.||lipid peroxidation inhibitor